Staying current with emerging research is essential for delivering evidence-based allergy and rhinology care. The latest AAOA Journal Club session provides a valuable review of recent literature impacting the diagnosis and management of allergic and inflammatory conditions encountered in otolaryngology…
FDA Approves First Generic Version of EpiPen
The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr.
FDA Commissioner Scott Gottlieb, M.D states that “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages…”
